COMPUGEN LTD (CGEN) Executive Compensation
COMPUGEN LTD (CGEN) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CGEN
CIK: 1119774
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: L3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Kost Forer Gabbay & Kasierer
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerEliran Ben Shabat
Audit LocationTel Aviv, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-09-10 | 2026-09-10 | 6-K | 0001178913-26-004494 | View SEC Doc Filr Page |
| UPLOAD | 2026-08-04 | — | UPLOAD Filing | 0000000000-26-007673 | View SEC Doc Filr Page |
| 6-K | 2026-08-03 | 2026-08-03 | 6-K | 0001178913-26-003756 | View SEC Doc Filr Page |
| 6-K | 2026-08-03 | 2026-06-30 | 6-K | 0001178913-26-003754 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-29 | FORM 4 | 0001178913-26-003729 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-29 | FORM 4 | 0001178913-26-003727 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-29 | FORM 4 | 0001178913-26-003725 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-29 | FORM 4 | 0001178913-26-003723 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-29 | FORM 4 | 0001178913-26-003721 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-29 | FORM 4 | 0001178913-26-003719 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-29 | FORM 4 | 0001178913-26-003717 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-29 | FORM 4 | 0001178913-26-003715 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-29 | FORM 4 | 0001178913-26-003713 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-29 | FORM 4 | 0001178913-26-003711 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-29 | FORM 4 | 0001178913-26-003709 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-29 | FORM 4 | 0001178913-26-003706 | View SEC Doc Filr Page |
| CORRESP | 2026-07-28 | — | CORRESP Filing | 0001178913-26-003609 | View SEC Doc Filr Page |
| UPLOAD | 2026-07-17 | — | UPLOAD Filing | 0000000000-26-007171 | View SEC Doc Filr Page |
| 4 | 2026-07-13 | 2026-07-09 | 4 Filing | 0001178913-26-003472 | View SEC Doc Filr Page |
| EFFECT | 2026-06-08 | — | EFFECT Filing | 9999999995-26-001920 | View SEC Doc Filr Page |
| CORRESP | 2026-06-04 | — | CORRESP Filing | 0001178913-26-003105 | View SEC Doc Filr Page |
| UPLOAD | 2026-05-21 | — | UPLOAD Filing | 0000000000-26-005217 | View SEC Doc Filr Page |
| F-3 | 2026-05-18 | — | F-3 | 0001178913-26-002774 | View SEC Doc Filr Page |
| 6-K | 2026-05-18 | 2026-05-18 | ZK2635352 | 0001178913-26-002750 | View SEC Doc Filr Page |
| 4 | 2026-04-27 | 2026-04-24 | 4 Filing | 0001178913-26-002245 | View SEC Doc Filr Page |